Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 5, pp. 510 - 519
Summary Background Listeriosis is a severe foodborne infection and a notifiable disease in France. We did a nationwide prospective study to characterise its...
Infectious Disease | MORTALITY | MENINGITIS | INFECTIOUS DISEASES | MONOCYTOGENES | RISK-FACTORS | MANAGEMENT | GUIDELINES | SURVEILLANCE | PREGNANCY | Foodborne Diseases - microbiology | Infant, Newborn, Diseases - epidemiology | Prognosis | Prospective Studies | Humans | Listeriosis - diagnosis | Bacteremia - mortality | Male | Infant, Newborn, Diseases - microbiology | Listeriosis - epidemiology | Mandatory Reporting | Listeria monocytogenes - classification | Adult | Female | Pregnancy Complications, Infectious - microbiology | Infant, Newborn | Meningoencephalitis - epidemiology | France - epidemiology | Meningoencephalitis - mortality | Pregnancy Complications, Infectious - epidemiology | Risk Factors | Listeria monocytogenes - isolation & purification | Hospitalization | Infectious Disease Transmission, Vertical | Pregnancy | Meningoencephalitis - microbiology | Bacteremia - epidemiology | Listeriosis - microbiology | Aged | Population Surveillance | Listeriosis | Neonates | Food-borne diseases | Disease | Brain stem | Clinical trials | Infections | Genomes | Gestation | Epidemiology | Risk factors | Windows (intervals) | Listeria | Meningitis | Public health | Food | Dexamethasone | Bacterial infections | Mortality | Fetuses | Regression analysis | Clustering | Patients | Bacteremia | Meningoencephalitis | Studies | Surveillance | Medical prognosis | Health risk assessment | Cancer | Life Sciences
Infectious Disease | MORTALITY | MENINGITIS | INFECTIOUS DISEASES | MONOCYTOGENES | RISK-FACTORS | MANAGEMENT | GUIDELINES | SURVEILLANCE | PREGNANCY | Foodborne Diseases - microbiology | Infant, Newborn, Diseases - epidemiology | Prognosis | Prospective Studies | Humans | Listeriosis - diagnosis | Bacteremia - mortality | Male | Infant, Newborn, Diseases - microbiology | Listeriosis - epidemiology | Mandatory Reporting | Listeria monocytogenes - classification | Adult | Female | Pregnancy Complications, Infectious - microbiology | Infant, Newborn | Meningoencephalitis - epidemiology | France - epidemiology | Meningoencephalitis - mortality | Pregnancy Complications, Infectious - epidemiology | Risk Factors | Listeria monocytogenes - isolation & purification | Hospitalization | Infectious Disease Transmission, Vertical | Pregnancy | Meningoencephalitis - microbiology | Bacteremia - epidemiology | Listeriosis - microbiology | Aged | Population Surveillance | Listeriosis | Neonates | Food-borne diseases | Disease | Brain stem | Clinical trials | Infections | Genomes | Gestation | Epidemiology | Risk factors | Windows (intervals) | Listeria | Meningitis | Public health | Food | Dexamethasone | Bacterial infections | Mortality | Fetuses | Regression analysis | Clustering | Patients | Bacteremia | Meningoencephalitis | Studies | Surveillance | Medical prognosis | Health risk assessment | Cancer | Life Sciences
Journal Article
Nature Genetics, ISSN 1061-4036, 2014, Volume 46, Issue 5, pp. 424 - 426
Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is a rare, highly aggressive form of ovarian cancer primarily diagnosed in young women. We...
HYPERCALCEMIC TYPE | CHROMATIN REMODELING FACTOR | CANCERS | BRG1 | GENETICS & HEREDITY | Immunohistochemistry | Carcinoma, Small Cell - genetics | Humans | Computational Biology | DNA, Complementary - genetics | Molecular Sequence Data | Chromatin Assembly and Disassembly - genetics | Transcription Factors - genetics | Mutation - genetics | Sequence Analysis, DNA | Ovarian Neoplasms - genetics | Base Sequence | Female | Gene Components | Nuclear Proteins - genetics | DNA Helicases - genetics | Genetic aspects | DNA binding proteins | Gene mutations | Health aspects | Ovarian cancer | Proteins | Studies | Medical research | Amino acids | Protein expression | Mutation | Gene expression | Cancer therapies | Tumors
HYPERCALCEMIC TYPE | CHROMATIN REMODELING FACTOR | CANCERS | BRG1 | GENETICS & HEREDITY | Immunohistochemistry | Carcinoma, Small Cell - genetics | Humans | Computational Biology | DNA, Complementary - genetics | Molecular Sequence Data | Chromatin Assembly and Disassembly - genetics | Transcription Factors - genetics | Mutation - genetics | Sequence Analysis, DNA | Ovarian Neoplasms - genetics | Base Sequence | Female | Gene Components | Nuclear Proteins - genetics | DNA Helicases - genetics | Genetic aspects | DNA binding proteins | Gene mutations | Health aspects | Ovarian cancer | Proteins | Studies | Medical research | Amino acids | Protein expression | Mutation | Gene expression | Cancer therapies | Tumors
Journal Article
Nature Communications, ISSN 2041-1723, 12/2017, Volume 8, Issue 1, pp. 990 - 9
Many high-grade serous carcinomas (HGSCs) of the pelvis are thought to originate in the distal portion of the fallopian tube. Serous tubal intra-epithelial...
PATHOGENESIS | ORIGIN | PRECURSOR | EPITHELIUM | MULTIDISCIPLINARY SCIENCES | FALLOPIAN-TUBE | TP53 MUTATIONS | MODEL | CANCER | EXPRESSION | CELL | Peritoneal Neoplasms - pathology | Adenocarcinoma in Situ - pathology | Adenocarcinoma in Situ - genetics | Neoplasms, Cystic, Mucinous, and Serous - pathology | Neoplasms, Multiple Primary - genetics | Humans | Middle Aged | Ovarian Neoplasms - pathology | Transcriptome | Fallopian Tube Neoplasms - pathology | Neoplasms, Multiple Primary - pathology | RNA, Messenger - metabolism | Case-Control Studies | Neoplasms, Cystic, Mucinous, and Serous - genetics | Ovarian Neoplasms - genetics | Neoplasm Grading | Peritoneal Neoplasms - genetics | Fallopian Tube Neoplasms - genetics | Adult | Female | Aged | Neoplasm Staging | Genomic analysis | Ovarian carcinoma | Nucleotide sequence | MiRNA | Fallopian tube | Pelvis | Tissues | Epithelium | Ribonucleic acids | Etiology | Lesions | Deoxyribonucleic acid--DNA | Tumors | Peritoneum | Cancer
PATHOGENESIS | ORIGIN | PRECURSOR | EPITHELIUM | MULTIDISCIPLINARY SCIENCES | FALLOPIAN-TUBE | TP53 MUTATIONS | MODEL | CANCER | EXPRESSION | CELL | Peritoneal Neoplasms - pathology | Adenocarcinoma in Situ - pathology | Adenocarcinoma in Situ - genetics | Neoplasms, Cystic, Mucinous, and Serous - pathology | Neoplasms, Multiple Primary - genetics | Humans | Middle Aged | Ovarian Neoplasms - pathology | Transcriptome | Fallopian Tube Neoplasms - pathology | Neoplasms, Multiple Primary - pathology | RNA, Messenger - metabolism | Case-Control Studies | Neoplasms, Cystic, Mucinous, and Serous - genetics | Ovarian Neoplasms - genetics | Neoplasm Grading | Peritoneal Neoplasms - genetics | Fallopian Tube Neoplasms - genetics | Adult | Female | Aged | Neoplasm Staging | Genomic analysis | Ovarian carcinoma | Nucleotide sequence | MiRNA | Fallopian tube | Pelvis | Tissues | Epithelium | Ribonucleic acids | Etiology | Lesions | Deoxyribonucleic acid--DNA | Tumors | Peritoneum | Cancer
Journal Article
Modern Pathology, ISSN 0893-3952, 01/2016, Volume 29, Issue 1, pp. 60 - 66
Small cell carcinoma of the ovary, hypercalcemic type is an aggressive tumor generally affecting young women with limited treatment options. Mutations in...
GENE | BRG1 | REACTIVATION | STRATEGY | COMPLEXES | MUTATIONS | PATHOLOGY | BRM | CANCER | LINES | Hypercalcemia - genetics | Ovary - pathology | Carcinoma, Small Cell - genetics | Hypercalcemia - pathology | Carcinoma, Small Cell - metabolism | Humans | Ovarian Neoplasms - pathology | Hypercalcemia - metabolism | Nuclear Proteins - metabolism | Transcription Factors - genetics | Ovarian Neoplasms - genetics | Transcription Factors - metabolism | Young Adult | DNA Helicases - metabolism | Cell Line, Tumor | Adult | Female | Ovarian Neoplasms - metabolism | Mutation | Carcinoma, Small Cell - pathology | Nuclear Proteins - genetics | DNA Helicases - genetics | Ovary - metabolism | Original
GENE | BRG1 | REACTIVATION | STRATEGY | COMPLEXES | MUTATIONS | PATHOLOGY | BRM | CANCER | LINES | Hypercalcemia - genetics | Ovary - pathology | Carcinoma, Small Cell - genetics | Hypercalcemia - pathology | Carcinoma, Small Cell - metabolism | Humans | Ovarian Neoplasms - pathology | Hypercalcemia - metabolism | Nuclear Proteins - metabolism | Transcription Factors - genetics | Ovarian Neoplasms - genetics | Transcription Factors - metabolism | Young Adult | DNA Helicases - metabolism | Cell Line, Tumor | Adult | Female | Ovarian Neoplasms - metabolism | Mutation | Carcinoma, Small Cell - pathology | Nuclear Proteins - genetics | DNA Helicases - genetics | Ovary - metabolism | Original
Journal Article
Nature genetics, ISSN 1061-4036, 2017, Volume 49, Issue 5, pp. 680 - 691
To identify common alleles associated with different histotypes of epithelial ovarian cancer (EOC), we pooled data from multiple genome-wide genotyping...
BREAST-CANCER | COMMON VARIANTS | METAANALYSIS | CLEAR-CELL | ALGORITHM | GENETICS & HEREDITY | RISK | ASSOCIATION | CARCINOMA | ENDOMETRIOSIS | TELOMERE LENGTH | Neoplasms, Glandular and Epithelial - pathology | Genetic Predisposition to Disease - genetics | Genome-Wide Association Study | Meta-Analysis as Topic | Humans | Risk Factors | Genetic Loci - genetics | Ovarian Neoplasms - pathology | Genotype | Ovarian Neoplasms - genetics | BRCA1 Protein - genetics | Neoplasms, Glandular and Epithelial - genetics | Telomere-Binding Proteins - genetics | Alleles | Carcinoma, Ovarian Epithelial | Female | Polymorphism, Single Nucleotide | Mutation | BRCA2 Protein - genetics | Genetic susceptibility | Physiological aspects | Genetic aspects | Single nucleotide polymorphisms | Identification and classification | Health aspects | Risk factors | Ovarian cancer | Carriers | Medical research | Ovarian carcinoma | Genes | Gene regulation | Genomes | Breast cancer | Loci | Cancer | Life Sciences | Human health and pathology | Genetics | Medical and Health Sciences | Medicin och hälsovetenskap
BREAST-CANCER | COMMON VARIANTS | METAANALYSIS | CLEAR-CELL | ALGORITHM | GENETICS & HEREDITY | RISK | ASSOCIATION | CARCINOMA | ENDOMETRIOSIS | TELOMERE LENGTH | Neoplasms, Glandular and Epithelial - pathology | Genetic Predisposition to Disease - genetics | Genome-Wide Association Study | Meta-Analysis as Topic | Humans | Risk Factors | Genetic Loci - genetics | Ovarian Neoplasms - pathology | Genotype | Ovarian Neoplasms - genetics | BRCA1 Protein - genetics | Neoplasms, Glandular and Epithelial - genetics | Telomere-Binding Proteins - genetics | Alleles | Carcinoma, Ovarian Epithelial | Female | Polymorphism, Single Nucleotide | Mutation | BRCA2 Protein - genetics | Genetic susceptibility | Physiological aspects | Genetic aspects | Single nucleotide polymorphisms | Identification and classification | Health aspects | Risk factors | Ovarian cancer | Carriers | Medical research | Ovarian carcinoma | Genes | Gene regulation | Genomes | Breast cancer | Loci | Cancer | Life Sciences | Human health and pathology | Genetics | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. e13521 - e13521
Journal Article
Cell Reports, ISSN 2211-1247, 01/2016, Volume 14, Issue 3, pp. 429 - 439
High-grade serous ovarian carcinomas (HGSOCs) with mutations exhibit improved outcome and sensitivity to double-strand DNA break (DSB)-inducing agents (i.e.,...
REPAIR | RESECTION | 53BP1 | DNA-DAMAGE | BREAKS | CELL-CYCLE | HOMOLOGOUS RECOMBINATION | DEFICIENCY | CELL BIOLOGY | MicroRNAs - antagonists & inhibitors | Homologous Recombination - drug effects | Antigens, Nuclear - metabolism | Humans | Oligonucleotides, Antisense - metabolism | Ovarian Neoplasms - pathology | MicroRNAs - metabolism | Intracellular Signaling Peptides and Proteins - metabolism | Ovarian Neoplasms - mortality | Organoplatinum Compounds - pharmacology | DNA-Binding Proteins - metabolism | Ovarian Neoplasms - genetics | RNA Interference | BRCA1 Protein - metabolism | Base Sequence | Female | Antineoplastic Agents - pharmacology | Intracellular Signaling Peptides and Proteins - genetics | DNA End-Joining Repair - drug effects | DNA-Binding Proteins - antagonists & inhibitors | DNA-Binding Proteins - genetics | BRCA1 Protein - genetics | Disease-Free Survival | Poly(ADP-ribose) Polymerase Inhibitors - pharmacology | Sequence Alignment | Animals | Antigens, Nuclear - genetics | Ku Autoantigen | Cell Line, Tumor | Mice | MicroRNAs - genetics | Tumor Suppressor p53-Binding Protein 1
REPAIR | RESECTION | 53BP1 | DNA-DAMAGE | BREAKS | CELL-CYCLE | HOMOLOGOUS RECOMBINATION | DEFICIENCY | CELL BIOLOGY | MicroRNAs - antagonists & inhibitors | Homologous Recombination - drug effects | Antigens, Nuclear - metabolism | Humans | Oligonucleotides, Antisense - metabolism | Ovarian Neoplasms - pathology | MicroRNAs - metabolism | Intracellular Signaling Peptides and Proteins - metabolism | Ovarian Neoplasms - mortality | Organoplatinum Compounds - pharmacology | DNA-Binding Proteins - metabolism | Ovarian Neoplasms - genetics | RNA Interference | BRCA1 Protein - metabolism | Base Sequence | Female | Antineoplastic Agents - pharmacology | Intracellular Signaling Peptides and Proteins - genetics | DNA End-Joining Repair - drug effects | DNA-Binding Proteins - antagonists & inhibitors | DNA-Binding Proteins - genetics | BRCA1 Protein - genetics | Disease-Free Survival | Poly(ADP-ribose) Polymerase Inhibitors - pharmacology | Sequence Alignment | Animals | Antigens, Nuclear - genetics | Ku Autoantigen | Cell Line, Tumor | Mice | MicroRNAs - genetics | Tumor Suppressor p53-Binding Protein 1
Journal Article
Journal of Medical Genetics, ISSN 0022-2593, 12/2016, Volume 53, Issue 12, pp. 800 - 811
BackgroundThe rarity of mutations in PALB2, CHEK2 and ATM make it difficult to estimate precisely associated cancer risks. Population-based family studies have...
GENE | BRCA2-INTERACTING PROTEIN | GENETICS & HEREDITY | SUSCEPTIBILITY LOCI | MUTATIONS | BRCA1 | BREAST | Prostatic Neoplasms - metabolism | Genetic Predisposition to Disease | Genetic Association Studies | Humans | Male | Risk | Case-Control Studies | Breast Neoplasms - metabolism | Ovarian Neoplasms - epidemiology | Prostatic Neoplasms - epidemiology | Ovarian Neoplasms - genetics | Checkpoint Kinase 2 - genetics | Breast Neoplasms - genetics | Prostatic Neoplasms - genetics | Tumor Suppressor Proteins - genetics | Female | Ovarian Neoplasms - metabolism | Mutation | Ataxia Telangiectasia Mutated Proteins - genetics | Nuclear Proteins - genetics | Fanconi Anemia Complementation Group N Protein | Breast Neoplasms - epidemiology | Breast cancer | Genetic aspects | Research | BRCA mutations | Genetic variation | Risk factors | Cancer: breast | Cancer: ovary | Genetics | cancer predisposition | 1507 | Cancer Genetics | Cancer: prostate | 1506
GENE | BRCA2-INTERACTING PROTEIN | GENETICS & HEREDITY | SUSCEPTIBILITY LOCI | MUTATIONS | BRCA1 | BREAST | Prostatic Neoplasms - metabolism | Genetic Predisposition to Disease | Genetic Association Studies | Humans | Male | Risk | Case-Control Studies | Breast Neoplasms - metabolism | Ovarian Neoplasms - epidemiology | Prostatic Neoplasms - epidemiology | Ovarian Neoplasms - genetics | Checkpoint Kinase 2 - genetics | Breast Neoplasms - genetics | Prostatic Neoplasms - genetics | Tumor Suppressor Proteins - genetics | Female | Ovarian Neoplasms - metabolism | Mutation | Ataxia Telangiectasia Mutated Proteins - genetics | Nuclear Proteins - genetics | Fanconi Anemia Complementation Group N Protein | Breast Neoplasms - epidemiology | Breast cancer | Genetic aspects | Research | BRCA mutations | Genetic variation | Risk factors | Cancer: breast | Cancer: ovary | Genetics | cancer predisposition | 1507 | Cancer Genetics | Cancer: prostate | 1506
Journal Article